title: Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy.
abstract: At the Fifth International Workshop on Peritoneal Surface Malignancy, in Milan, the consensus on technical aspects of cytoreductive surgery (CRS) for peritoneal surface malignancy was obtained through the Delphi process. Conflicting points concerning drugs, carrier solution and optimal temperature for hyperthermic intraperitoneal chemotherapy (HIPEC) were discussed.
authors: Department of Surgery, National Cancer Institute of Milan, Italy.
authors: Shigeki
authors: S
authors: Kusamura
authors: Elias
authors: E
authors: Dominique
authors: Dario
authors: D
authors: Baratti
authors: Rami
authors: R
authors: Younan
authors: Marcello
authors: M
authors: Deraco
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017024:Chemotherapy, Adjuvant; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000379:methods*; D004337:Drug Carriers; D006801:Humans; D006979:Hyperthermia, Induced / Q000379:methods*; D007263:Infusions, Parenteral; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000601:surgery*
chemical_list: D000970:Antineoplastic Agents; D004337:Drug Carriers